Atlas Trials

FET PET in Differentiating Tumour Progression From Pseudoprogression in High Grade Glioma

Clinical trial NCT06172595 · RECRUITING

Trial details

NCT number
NCT06172595
Sponsor
Singapore General Hospital
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Glioma, Malignant
Start date
2023-12-21
Primary completion
2025-12-31
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.